Drug Delivery Systems Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Drug Delivery Systems Market
The drug delivery systems market size was valued at USD 42.71 billion in 2023, and the market is now projected to grow from USD 46.23 billion in 2024 to USD 96.34 billion by 2032, exhibiting a CAGR of 9.6% during the forecast period of 2023-2030.
The COVID-19 pandemic has influenced the drug delivery market drastically. Initially, the global supply chain incidents and manufacturing challenges led to some sort of disruptions but, the demand for sophisticated drug delivery technologies jumped as the healthcare systems were focusing on the non-contact as well as remote mode of treatment. This increase resulted in the development of technologies such as injectable/implantable drug delivery systems and innovations in targeted delivery.
The major factors behind Drug delivery systems market growth are improvements in technologies, higher frequency of chronic diseases and escalating demand for selective drug delivery. Advances in nanoscience, implantable devices and transdermal patches are increasing drug effectiveness and patient compliance. Besides that, increase in the geriatric population as well as the growing pharmaceutical industry are also leading to the market extension. By the support of the research and development activities, as well as by implementing the suitable regulations, the market is expected to grow rapidly in the future.
The drug delivery systems market is seeing a variety of trends. Nanotechnology-based delivery systems have become increasingly popular as they are capable of increasing drug bioavailability and target desirable sites. Sustainable drug releasing biodegradable implants are currently being used more and more. Personalized drugs is the basis of the new generation of biotechnology drugs designed to satisfy the requirement of each patient. Moreover, recent developments in microfluidic devices and portable wearables make personalized therapeutics precise and convenient.
Comprehensive Analysis of Drug Delivery Systems Market
The drug delivery systems industry is rising at an exponential rate due to its market segmentation. These segmentations are methodically segregated by type, by device type and by distribution channel. Based on type, market is divided into inhalation, transdermal, injectable and others. Based on device type, market is divided into conventional and advanced. Based on distribution channel, market is divided into hospital pharmacies, retail pharmacies and others.
The North America holds leading position in drug delivery systems market share by benefitting a market size of USD 17.33 billion in 2023 due to an advanced healthcare infrastructure, extensive R&D and wide application of novel technologies. The region provides strong government backing and regulatory systems that make the program work. Also, key market players and strategic partnerships with research organizations help it to occupy the leading position in the market.
The top players in the market play a crucial role in the healthcare industry assuring industrial prospectus growth and setting market standards. These players include, Gerresheimer AG (Germany), BD (Becton, Dickinson and Company) (U.S), Kindeva Drug Delivery (U.S.), Baxter (U.S.), West Pharmaceutical Services Inc. (U.S.), Ypsomed (Switzerland), Medtronic (Ireland), Nemara (France), E3D Elcam Drug Delivery Devices (Israel). These market players provide a level-playing competitive landscape.
October 2023: Gerresheimer initiated Open Innovation Project for the creation of home therapy tools.
Segmentation Table
Global Drug Delivery Systems Market Scope
Study Period 2019-2032
Base Year 2023
Estimated Year 2024
Forecast Period 2024-2032
Historical Period 2019-2022
Growth Rate CAGR of 9.6% from 2024-2032
Unit Value (USD billion)
Segmentation
By Type
Inhalation
Transdermal
Injectable
Others
By Device Type
Conventional
Advanced
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Others
By Region
North America (By Type, Device Type, Distribution Channel, and Country)
U.S.
Canada
Europe (By Type, Device Type, Distribution Channel, and Country/Sub-region)
U.K.
Germany
France
Spain
Italy
Scandinavia
Rest of Europe
Asia Pacific (By Type, Device Type, Distribution Channel, and Country/Sub-region)
China
India
Japan
Australia
Southeast Asia
Rest of Asia Pacific
Latin America (By Type, Device Type, Distribution Channel, and Country/Sub-region)
Brazil
Mexico
Rest of Latin America
Middle East & Africa (By Type, Device Type, Distribution Channel, and Country/Sub-region)
GCC
South Africa
Rest of the Middle East & Africa
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Market Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. New Product Launches, By Key Players
- 4.2. Technological Advancements in the Drug Device Systems
- 4.3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
- 4.4. Impact of Drug Delivery Systems on Stakeholders
- 4.5. Impact of COVID-19 on the Market
- 5. Global Drug Delivery Systems Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast – By Type
- 5.1.1. Inhalation
- 5.1.2. Transdermal
- 5.1.3. Injectable
- 5.1.4. Others
- 5.2. Market Analysis, Insights and Forecast – By Device Type
- 5.2.1. Conventional
- 5.2.2. Advanced
- 5.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 5.3.1. Hospitals Pharmacies
- 5.3.2. Retail Pharmacies
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
- 6. North America Drug Delivery Systems Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast – By Type
- 6.1.1. Inhalation
- 6.1.2. Transdermal
- 6.1.3. Injectable
- 6.1.4. Others
- 6.2. Market Analysis, Insights and Forecast – By Device Type
- 6.2.1. Conventional
- 6.2.2. Advanced
- 6.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 6.3.1. Hospitals Pharmacies
- 6.3.2. Retail Pharmacies
- 6.3.3. Others
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
- 7. Europe Drug Delivery Systems Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast – By Type
- 7.1.1. Inhalation
- 7.1.2. Transdermal
- 7.1.3. Injectable
- 7.1.4. Others
- 7.2. Market Analysis, Insights and Forecast – By Device Type
- 7.2.1. Conventional
- 7.2.2. Advanced
- 7.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.3.1. Hospitals Pharmacies
- 7.3.2. Retail Pharmacies
- 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 7.4.1. Germany
- 7.4.2. U.K.
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Scandinavia
- 7.4.7. Rest of Europe
- 8. Asia Pacific Drug Delivery Systems Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast – By Type
- 8.1.1. Inhalation
- 8.1.2. Transdermal
- 8.1.3. Injectable
- 8.1.4. Others
- 8.2. Market Analysis, Insights and Forecast – By Device Type
- 8.2.1. Conventional
- 8.2.2. Advanced
- 8.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.3.1. Hospitals Pharmacies
- 8.3.2. Retail Pharmacies
- 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 8.4.1. India
- 8.4.2. China
- 8.4.3. Japan
- 8.4.4. Australia
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
- 9. Latin America Drug Delivery Systems Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast – By Type
- 9.1.1. Inhalation
- 9.1.2. Transdermal
- 9.1.3. Injectable
- 9.1.4. Others
- 9.2. Market Analysis, Insights and Forecast – By Device Type
- 9.2.1. Conventional
- 9.2.2. Advanced
- 9.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 9.3.1. Hospitals Pharmacies
- 9.3.2. Retail Pharmacies
- 9.3.3. Others
- 9.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
- 10. Middle East & Africa Drug Delivery Systems Market Analysis, Insights and Forecast, 2019-2032
- 10.1. Market Analysis, Insights and Forecast – By Type
- 10.1.1. Inhalation
- 10.1.2. Transdermal
- 10.1.3. Injectable
- 10.1.4. Others
- 10.2. Market Analysis, Insights and Forecast – By Device Type
- 10.2.1. Conventional
- 10.2.2. Advanced
- 10.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 10.3.1. Hospitals Pharmacies
- 10.3.2. Retail Pharmacies
- 10.3.3. Others
- 10.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 10.4.1. GCC
- 10.4.2. South Africa
- 10.4.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis (2023)
- 11.2. Company Profiles
- 11.2.1. Medtronic
- 11.2.1.1. Overview
- 11.2.1.2. Products & Services
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Ypsomed AG
- 11.2.2.1. Overview
- 11.2.2.2. Products & Services
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Nemera
- 11.2.3.1. Overview
- 11.2.3.2. Products & Services
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. BD (Becton, Dickinson and Company)
- 11.2.4.1. Overview
- 11.2.4.2. Products & Services
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Gerresheimer AG
- 11.2.5.1. Overview
- 11.2.5.2. Products & Services
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. West Pharmaceutical Services, Inc.
- 11.2.6.1. Overview
- 11.2.6.2. Products & Services
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. West Pharmaceutical Services, Inc.
- 11.2.7.1. Overview
- 11.2.7.2. Products & Services
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. KINDEVA DRUG DELIVERY
- 11.2.8.1. Overview
- 11.2.8.2. Products & Services
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. E3D Elcam Drug Delivery Devices
- 11.2.9.1. Overview
- 11.2.9.2. Products & Services
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook